X Bertrán

1.7k total citations
16 papers, 499 citations indexed

About

X Bertrán is a scholar working on Epidemiology, Surgery and Physiology. According to data from OpenAlex, X Bertrán has authored 16 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Surgery and 4 papers in Physiology. Recurrent topics in X Bertrán's work include Liver Disease Diagnosis and Treatment (6 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Inflammatory Bowel Disease (4 papers). X Bertrán is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Inflammatory Bowel Disease (4 papers). X Bertrán collaborates with scholars based in Spain, Canada and Ireland. X Bertrán's co-authors include Fernando Fernández‐Bañares, Eduard Cabré, María Esteve, M.À. Gassull, Ramón Planas, Eugeni Domènech, Isabel Ojanguren, M.A. Gassull, E. Cabré and P. Humbert and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

X Bertrán

16 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
X Bertrán Spain 10 318 246 122 119 56 16 499
A van der Sluys Veer Netherlands 13 197 0.6× 160 0.7× 94 0.8× 71 0.6× 64 1.1× 21 412
H. J. Steinhardt Germany 8 293 0.9× 380 1.5× 242 2.0× 58 0.5× 125 2.2× 12 581
Roxana Vădan Romania 12 294 0.9× 132 0.5× 107 0.9× 205 1.7× 36 0.6× 19 408
P.R. Dal Monte Italy 11 212 0.7× 149 0.6× 180 1.5× 111 0.9× 13 0.2× 29 468
Dragan Popović Serbia 15 216 0.7× 104 0.4× 148 1.2× 89 0.7× 13 0.2× 44 462
M. N. Eade New Zealand 7 169 0.5× 100 0.4× 161 1.3× 164 1.4× 22 0.4× 13 362
Juris Pokrotnieks Latvia 11 405 1.3× 528 2.1× 195 1.6× 45 0.4× 16 0.3× 26 680
Zsuzsanna Vitális Hungary 13 352 1.1× 135 0.5× 109 0.9× 289 2.4× 11 0.2× 34 544
Danny J. Avalos United States 9 173 0.5× 122 0.5× 88 0.7× 84 0.7× 12 0.2× 24 328
T. Kanaghinis Greece 7 209 0.7× 202 0.8× 183 1.5× 46 0.4× 31 0.6× 14 420

Countries citing papers authored by X Bertrán

Since Specialization
Citations

This map shows the geographic impact of X Bertrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X Bertrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X Bertrán more than expected).

Fields of papers citing papers by X Bertrán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X Bertrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X Bertrán. The network helps show where X Bertrán may publish in the future.

Co-authorship network of co-authors of X Bertrán

This figure shows the co-authorship network connecting the top 25 collaborators of X Bertrán. A scholar is included among the top collaborators of X Bertrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X Bertrán. X Bertrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mañé, Josep, Fernando Fernández‐Bañares, Isabel Ojanguren, et al.. (2001). Effect of L-arginine on the course of experimental colitis. Clinical Nutrition. 20(5). 415–422. 21 indexed citations
2.
Vega, Roser, X Bertrán, Eugeni Domènech, et al.. (1999). Cytomegalovirus Infection in Patients With Inflammatory Bowel Disease. The American Journal of Gastroenterology. 94(4). 1053–1056. 98 indexed citations
3.
Domènech, Eugeni, Xavier Aldeguer, E. Cabré, et al.. (1998). Azathioprine in inflammatory bowel disease: An 8-year study and assessment of response predictors. Gastroenterology. 114. A967–A967. 3 indexed citations
4.
Fernández‐Bañares, Fernando, María Esteve, Josep Mañé, et al.. (1997). Changes in mucosal fatty acid profile in inflammatory bowel disease and in experimental colitis: a common response to bowel inflammation. Clinical Nutrition. 16(4). 177–183. 28 indexed citations
5.
Bertrán, X, Fernando Fernández‐Bañares, E. Castellà, et al.. (1996). Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.. Gut. 38(6). 899–904. 28 indexed citations
6.
Fernández‐Bañares, Fernando, X Bertrán, María Esteve, et al.. (1996). Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.. PubMed. 91(12). 2498–9. 107 indexed citations
7.
Esteve, María, Josep Mallolas, Julieta Klaassen, et al.. (1996). Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.. Gut. 38(6). 894–898. 31 indexed citations
8.
Esteve, María, Marı́a Jesús Ramı́rez-Expósito, Fernando Fernández‐Bañares, et al.. (1995). Determinants of Plasma Fatty Acid Abnormalities in Patients with Active Inflammatory Bowel Disease: A Multivariate Analysis. Inflammatory Bowel Diseases. 1(2). 95–100. 7 indexed citations
9.
Cabré, Eduard, et al.. (1995). [Reliability of bioelectric impedance analysis as a method of nutritional monitoring in cirrhosis with ascites].. PubMed. 18(7). 359–65. 14 indexed citations
10.
Esteve, María, Marı́a Jesús Ramı́rez-Expósito, Fernando Fernández‐Bañares, et al.. (1995). Determinants of plasma fatty acid abnormalities in patients with active inflammatory bowel disease: A multivariate analysis. Inflammatory Bowel Diseases. 1(2). 95–100. 10 indexed citations
11.
Bertrán, X, Josep Mañé, Fernando Fernández‐Bañares, et al.. (1995). Intracolonic administration of zileuton, a selective 5-lipoxysenase inhibitor, decreases stricture formation and accelerates healing in a rat model of chronic colitis. Gastroenterology. 108(4). A782–A782. 4 indexed citations
12.
Esteve, María, Fernando Fernández‐Bañares, A Abad-Lacruz, et al.. (1993). Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.. Gut. 34(10). 1370–1373. 52 indexed citations
13.
Llovet, Josep M., Ramón Planas, R Morillas, et al.. (1993). Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study.. PubMed. 88(3). 388–92. 88 indexed citations
14.
Cabré, Eduard, Ramón Planas, Eva Domingo‐Doménech, et al.. (1992). Body impedance analysis (BIA) is not a reliable method for assessing body composition in cirrhotics with ascites. Clinical Nutrition. 11. 99–99. 3 indexed citations
15.
Bertrán, X, et al.. (1992). [Polymyositis-dermatomyositis associated with small-cell bronchogenic carcinoma and pulmonary tuberculosis].. PubMed. 190(5). 281–2. 3 indexed citations
16.
Bertrán, X, Fernando Fernández‐Bañares, Ramón Planas, et al.. (1991). [Impact on the energetic-proteic nutritional status of total paracentesis combined with infusion of albumin or dextran-70 in the therapy of tension ascites in liver cirrhosis].. PubMed. 79(5). 320–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026